A rustic still life with a beige cloth draped table featuring citrus fruits, jars, bottles, cheeses, and vibrant flowers in a bronze pitcher

EU Compliance

Your Compleme Compliance Service

Action required. May 1, 2026 — Omnibus VIII CMR bans take effect. No sell-through window. Products without a compliant reformulation must be withdrawn from market.
EU Transition Model

Your formulations are changing. We make sure you're ready.

The SOSOO EU Transition Model is a complete compliance service — from ingredient audit to market-ready documentation — aligned with the 2026–2027 enforcement timeline.

Critical Enforcement Dates
CRITICAL
May 1, 2026
Omnibus VIII CMR substance bans — immediate market withdrawal, no sell-through
HIGH
July 31, 2026
Fragrance allergen expansion — 82 substances, mandatory labelling on all new products
HIGH
H1 2027
Full market compliance — updated PIFs, CPSRs, CPNP notifications required
UPCOMING
October 2027
Microplastics restriction in rinse-off products
What We Cover

End-to-end regulatory transition.

Eight integrated capabilities that take your products from audit to compliant market entry. We handle the complexity — you focus on your brand.

⟳
Ingredient Substitution
We map every restricted or banned substance in your portfolio to a compliant alternative — evaluating efficacy, safety, and regulatory status.
⊙
Sandbox Testing
Reformulated products are validated in an isolated regulatory environment before any production commitment.
≡
Supplier Data Pipeline
We collect and normalise your supplier documentation — COAs, REACH registrations, SDS — into compliance-ready records.
◈
Label Compliance
Mandatory warnings, allergen thresholds, INCI naming — we generate label-ready text that meets every requirement.
⚠
Marketing Conflict Detection
We flag ingredients that are EU-legal but excluded by retail clean standards, so your products work in every sales channel.
✓
Market Readiness Verification
PIF, CPSR, CPNP, labelling, Responsible Person — a structured checklist to clear every pre-market requirement.
◷
Regulatory Timeline Management
Every enforcement date, transition window, and milestone mapped to your portfolio — so nothing is missed.
◎
Ongoing Monitoring
Regulations evolve. We track new CMR classifications, Annex amendments, and emerging restrictions continuously.
Regulatory Scope

Built on the full EU cosmetics framework.

Substance-level analysis across every Annex — not a simplified summary. Detailed restriction tables, concentration limits, and labelling rules specific to your portfolio.

Regulation (EC) No 1223/2009
Omnibus VIII (2026/78)
Annex II — Prohibited Substances
Annex III — Restricted Substances
Annex IV — Colorants
Annex V — Preservatives
Annex VI — UV Filters
82-Allergen Labelling Framework
CMR 1A/1B Classifications
CPNP Notification Requirements
Our transition model is grounded in the complete regulatory landscape.

When you engage with us, you receive detailed substance-level analysis, concentration limits, labelling rules, and substitution paths specific to your portfolio. Detailed restriction tables, ingredient databases, and compliance reports are provided as part of our service engagement.

How It Works

Five phases. Full compliance.

A structured engagement from audit to market — no assumptions, no shortcuts.

01
Portfolio Audit
Substance-level review of your full range
We review every product against current and incoming EU regulations — Annex II, III, IV, V, VI — and identify every substance that requires action. You receive a prioritised list with enforcement deadlines.
02
Substitution & Reformulation
Compliant alternatives for every flagged ingredient
Our substitution engine maps restricted ingredients to compliant alternatives. Each recommendation is validated for functional equivalence and regulatory clearance before it reaches you.
03
Testing & Validation
Regulatory sandbox before production commitment
Reformulated products are tested against concentration limits, CMR classifications, allergen thresholds, and labelling requirements — before any production costs are incurred.
04
Documentation & Filing
Complete PIF, CPSR, CPNP, and label text
We compile complete Product Information Files, updated CPSRs, CPNP notifications, and label-ready text — everything your Responsible Person needs to file and maintain compliance.
05
Market Entry & Monitoring
Launch-ready, then continuously monitored
Your products launch with full compliance documentation. We continue monitoring for new regulatory signals and Annex amendments that may affect your portfolio — so you never get caught off guard again.
Why Now

The regulatory clock is running.

Three critical enforcement dates are approaching. Products that miss these deadlines face immediate market withdrawal — no exceptions, no extensions.

May 1, 2026
Omnibus VIII Enforcement
Multiple CMR substances move to Annex II (banned). No transition period — all stock must be compliant by this date. There is no sell-through window.
July 31, 2026
Allergen List Expansion
The mandatory allergen labelling list expands to 82 substances. New additions include common fragrance compounds. Every product label must be updated before this date.
H1 2027
Full Market Compliance
All reformulated products must have updated PIFs, CPSRs, and CPNP notifications. Post-market surveillance plans must be active and documented.
Start a Project

Every transition starts with a conversation.

We work with a limited number of brands each quarter. Share your situation — we'll assess your portfolio and outline the path to full compliance.

OfficeC/ Francesc de borja moll 15, Palma, Mallorca
Emailcs@sosooamenities.com
Telephone+34 684 401 973

We respond within 1 business day. Regulatory guidance only — not legal advice.

© 2026 SOSOO Amenities · EU regulatory compliance guidance — not legal advice.